Sophia Genetics SA (SOPH) | Stock Overview & Key Data
Sophia Genetics SA Performance Comparison
Stock Range
Today's Range
Low: $3.22
High: $3.46
on September 5, 2025
52 Week Range
Low: $2.58
High: $4.92
on April 21, 2025
on February 19, 2025
All-Time High: $19.80 on August 30, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$219.0M
EPS
-1.10
P/E Ratio (TTM)
-3.41
Forward P/E
-4.00
P/B Ratio
2.85
PEG Ratio
-0.08
Div. Yield
N/A
ROE
-74.09%
Beta
1.016
Debt to Equity
83.21
Financial Highlights
Profitability
Gross Margin
66.97%
Operating Margin
-100.92%
Profit Margin
-105.32%
Returns and Earnings
Return on Assets (TTM)
-23.46%
Return on Equity (TTM)
-74.09%
EBITDA
$-65.9M
Net Income (TTM)
$-73.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$1.04
Quarterly Revenue Growth (YoY)
15.90%
Quarterly Earnings Growth (YoY)
15.91%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Sophia Genetics SA SOPH | 218.96M Micro-cap | -6.36% | -5.26% | 6.23% | 4.18% | 1.57% | -13.60% | 5.19% | -80.67% |
| Veeva Systems VEEV | 44.12B Large-cap | 1.39% | -3.03% | -5.87% | 24.09% | 29.61% | 26.42% | 52.31% | 3.18% |
| Ge Healthcare GEHC | 34.58B Large-cap | 2.71% | 7.05% | 5.84% | -10.65% | -3.38% | -11.00% | 33.47% | 33.47% |
| Health Catalyst HCAT | 237.86M Micro-cap | -0.29% | -11.52% | -11.98% | -25.71% | -53.95% | -53.64% | -70.71% | -90.20% |
| CareCloud CCLD | 148.13M Micro-cap | -9.11% | 46.64% | 61.57% | 11.86% | -8.40% | 50.43% | -26.37% | -62.95% |
| American Well AMWL | 108.54M Micro-cap | 1.16% | -17.69% | 0.87% | -20.23% | -0.85% | -11.98% | -91.94% | -98.48% |
Ownership & Short Interest
Insider Ownership
6.46%
Institutional Ownership
48.20%
Shares Short
41K
Short Ratio
0.53
Short % of Shares Outstanding
0.08%
Average 10-Day Volume
45K
Average 90-Day Volume
76K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SOPH's 52-week high and low?
- In the last 52 weeks, Sophia Genetics SA reached a high of $4.92 (on February 19, 2025) and a low of $2.58 (on April 21, 2025).
- What is the market cap and P/E ratio for SOPH?
- Curious about Sophia Genetics SA's size and valuation? Its market capitalization stands at 218.96M. When it comes to valuation, the P/E ratio (trailing twelve months) is -3.41, and the forward P/E (looking ahead) is -4.00.
- Does SOPH pay dividends? If so, what's the yield?
- As for dividends, Sophia Genetics SA isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Sophia Genetics SA's main competitors or similar companies to consider before investing?
When looking at Sophia Genetics SA, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Veeva Systems
VEEV44.12B Healthcare Health Information Services 26.42% 52.31% Ge Healthcare
GEHC34.58B Healthcare Health Information Services -11.00% 33.47% Health Catalyst
HCAT237.86M Healthcare Health Information Services -53.64% -70.71% CareCloud
CCLD148.13M Healthcare Health Information Services 50.43% -26.37% American Well
AMWL108.54M Healthcare Health Information Services -11.98% -91.94% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Sophia Genetics SA? (e.g., ROE, Debt/Equity)
- To get a sense of Sophia Genetics SA's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -74.09%, the Debt to Equity ratio from the most recent quarter is 83.21, and its Gross Profit Margin stands at 66.97%.
- What is the recent revenue and earnings growth for SOPH?
- Looking at Sophia Genetics SA's growth, its revenue over the trailing twelve months (TTM) was $70M. Compared to the same quarter last year (YoY), quarterly revenue grew by 15.90%, and quarterly earnings saw a YoY growth of 15.91%.
- How much of SOPH stock is held by insiders and institutions?
- Wondering who owns Sophia Genetics SA stock? Company insiders (like executives and directors) hold about 6.46% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 48.20%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.